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Imaging with [11C]-metformin in tumor bearing mice showed 
a large uptake in the kidneys and excretion through the 
bladder, as expected for metformin. An uptake of [11C]-
metformin was seen in both A549 (lung) and SiHa (cervix) 
tumors and autoradiography supported this finding. 
Biodistribution of metformin in humans is shown in figure 1 
with visible uptake in liver, kidney and the salivary glands, 
but no detectable uptake in brain, muscle or adipose tissue. 
 
Conclusion: It is possible to visualize distribution of [11C]-
metformin in vivo. In xenograft models uptake in tumor was 
seen. It will be of great interest to investigate whether it is 
possible to visualize an uptake in human tumors, which will 
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Purpose or Objective: A high level of circulating osteopontin 
(OPN) at the end of radiotherapy (RT) is an adverse 
prognostic factor in patients with glioblastoma (GBM) and 
other tumours including rectum cancer. Recent mechanistic 
studies demonstrated HIF2α–mediated OPN/CD44 promotion 
of the glioma stem cell-like phenotype in a mouse model. 
Using unique paired tumour samples from patients with GBM, 
we investigated changes in levels of OPN protein expression 
following RT and compared these with rectum cancers from 
patients irradiated with the same pre-operative 
fractionation. 
 
Material and Methods: 3 patients with histologically 
confirmed GBM received pre-operative RT in an ethics-
approved Phase I trial. 2.5 Gy b.d. was delivered using IMRT 
over 5 days. Maximal safe tumour resection was performed at 
3, 5 and 10 days post RT in patients 1, 2 and 3 respectively. 
Immunohistochemistry was performed on the paired 
diagnostic biopsy and irradiated resection specimen using 
validated antibodies (rabbit polyclonal antibody to OPN: 
clone PA1-38332, Thermo Fisher Scientific) and an automated 
immunostainer. The staining was scored by a board-certified 
pathologist.  
 
Results: Levels of OPN in GBM tumour cells were high at 
baseline as compared with rectum adenocarcinoma. There 
was marked increase in OPN expression in response to RT in 
all three GBM tumours (Fig 1). Expression of Glut-1, a marker 
of intrinsic hypoxia and a target of HIF-2α, was not induced. 
Ki67 levels were reduced although levels of cyclin D1 
expression were unchanged. A dynamic contrast-enhanced 
(DCE) MRI performed on the last day of RT did not detect any 
change in tumour perfusion in any of the GBMs. Resection 
specimens from 3 rectum cancer patients irradiated 
preoperatively with the same schedule showed very low level 




Conclusion: RT increased the levels of OPN expression in 
GBM tumour cells. This may be a direct effect or related to 
RT-induced changes in the hypoxic tumour microenvironment 
that were not detectable on a DCE-MRI or by Glut-1 
expression. Although RT significantly increases overall 
survival compared with surgery alone, particularly when 
combined with temozolomide, it may promote the cancer 
stem cell-like phenotype of residual GBM cells. Enhanced 
OPN/CD44 signalling in the perivascular niche is associated 
with resistance to therapy and blockade of this signalling 
pathway may prove of clinical benefit. The relative lack of 
induction of OPN expression in rectum cancer may explain 
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Purpose or Objective: In process like reactive oxygen 
production and apoptosis mitochondria play an important role 
and both processes play also a significant role in radiotherapy 
(RT) response. Repair of RT induced damage is dependent on 
mitochondrial energy supply suggesting a role for 
mitochondrial DNA (mtDNA) in RT. mtDNA variations, such as 
mutations or depletion, might therefore influence RT 
response, as for example found in cisplatin-treated patients. 
Therefore carefully elucidating the effect of these processes 
in radiation response might be important. Hence, we 
hypothesize that reduced mitochondrial function enhances 
the radiation response as a consequence of reduced ATP 
production and increased cellular ROS exposure (Fig.1). 




Material and Methods: Three cell lines were depleted from 
their mtDNA by ethidium bromide. BEAS-2B immortalized 
bronchial epithelial, A549 lung adenocarcinoma and 143B 
osteosarcoma cell lines and their mtDNA depleted 
counterparts (ρ0) were metabolically characterized using the 
XF96 Seahorse. Changes in radiosensitivity were assessed by 
clonogenic survival (0, 2, 4, 6 and 8Gy). ROS production (by 
dihydrorhodamine FACS analysis), ATP (Cell-TiterGlo 
Luminescent cell viability test) and glutathione levels (in cell 
lysate) as well as γH2AX immunostainings were assessed 24 
hours post irradiation. 
 
Results: mtDNA depletion resulted in a significant (p<0.05) 
decreased proliferation (64 ± 7%) for all cell lines. Compared 
to their respective controls, increased clonogenic survival 
was observed for the BEAS-2B ρ0 cells (p=0.004) after 
irradiation, while both tumor ρ0 lines were more radiation 
sensitive (p=0.013), mainly at higher irradiation doses. ROS 
formation at baseline (0Gy) was similar (p=0.878) for BEAS-2B 
parental and ρ0, while reduced for A549 and 143B ρ0 
(p=0.021) cells, compared to their parental counterparts. 24 
hours after irradiation ROS levels were significantly (p<0.05) 
increased for all parental cell lines, while levels for the ρ0 
cells remained equal. Glutathione levels were lower for the 
A549 and 143B ρ0 cell lines compared to the parental lines 
under any experimental condition but no changes were found 
for the BEAS-2B cells. In agreement, increased residual DNA 
damage was observed upon mtDNA depletion for A549 and 
143B cells. Depletion of mtDNA reduced cellular ATP levels 
only for the BEAS-2B cell line (p=0.046), but not for the A549 
and 143B cell lines in high glucose culture medium. 
 
Conclusion: The observed differences in dependence on 
mitochondrial function for radioresponsiveness appear to be 
associated with the balance in ROS levels and the antioxidant 
status of the cells. Currently, the levels of MnSOD and GPX1 
and the effect of ROS scavenging on radiotherapy response 
are investigated in our lab. 
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Purpose or Objective: We have previously shown that 
lysosome-associated membrane protein-3 (LAMP3), a protein 
involved in the unfolded protein response pathway, is 
involved in resistance to both endocrine (tamoxifen) 
treatment and radiotherapy in breast cancer patients. We 
have created subclones of the MCF7 breast cancer cell line 
that are resistant to either treatment. In these subclones, we 
investigated common mechanisms between tamoxifen- and 
radioresistance, and the possible role of LAMP3 therein. 
Material and Methods: The estrogen receptor positive breast 
cancer cell line MCF7 was grown to tamoxifen resistance 
(MCF7TAM) by culturing with gradually increasing 
concentrations of 4-OH-tamoxifen up to 10 μM. Additionally, 
MCF7 cells were exposed to multiple fractions of 2 or 4 Gy 
irradiation, adding up to a total dose of at least 50 Gy 
(MCF7RT). Changes in expression profiles in MCF7TAM and 
MCF7RT cells compared to parental MCF7 cells were 
investigated by RNA sequencing. Pathway analysis software 
was used to find pathways involved in tamoxifen- and 
radioresistance. QPCR was used to confirm the RNA 
sequencing data, and to investigate the changes in genes of 
interest after tamoxifen treatment and irradiation.The role 
of LAMP3 in these treatment resistance pathways is being 
elucidated by performing LAMP3 gene silencing by siRNA and 
CRISPR-Cas mediated gene knockout.  
 
Results: The MCF7TAM cells were completely resistant to 
treatment with 10 μM 4-OH-tamoxifen. Remarkably, these 
cells had also become resistant to irradiation, with a 
surviving fraction at 4 Gy (SF4) of 19.7%, compared to 8.3% 
for the parental MCF7 cells. MCF7RT cells were less sensitive 
to irradiation with a SF4 of 9.6% compared to 3.9% for the 
parental cells. RNA sequencing of MCF7TAM and MCF7RT cells 
revealed an increase of genes involved in the antiviral 
response, including classic interferon response genes such as 
IFI6 (shown in figure, left), IFI27, STAT1, OAS1 and DDX60. 
These genes were increased in parental cells following 4 Gy 
irradiation (figure, right) or tamoxifen treatment as well. 
 
 
Conclusion: MCF7 cells resistant to tamoxifen treatment are 
also less sensitive to irradiation,suggesting a common 
mechanism in the resistance to these diverse types of 
treatment. Using an unbiased approach, we here show that 
interferon response genes are increased in both MCF7TAM 
and MCF7RT cells. Interestingly, others have shown LAMP3 to 
be a regulator for this pathway. We are currently 
investigating the role of LAMP3 in our treatment resistant 
breast cancer clones. 
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Purpose or Objective: The brain tumor glioblastoma 
multiforme (GBM) is highly malignant with a very short OS 
due to rapid recurrences adjacent to the primary tumor. 
Even radio-chemotherapy extends the survival only for a few 
months. In this project we tested whether or not the 
Slit2/Robo1 axon guidance system might be involved in the 
migration of metastatic GBM cells and whether irradiation 
with photons might modify this putative effect. 
 
Material and Methods: The experiments were performed 
with 2 human GBM cell lines (U87 and U373) and in parallel 
after irradiation with 0.5, 2, or 8 Gy photons. The 
motility/migration of the cells was analyzed by time-laps 
videography. Travelling cells were tracked and the 
parameters accumulated distance and Euclidean distance 
were determined. The expression of Slit2, Robo1, and FAK 
(focal adhesion kinase) was tested by Western blot and qRT-
PCR. In addition, the cells were transfected either with a 
Robo1 expression-vector or with a siRNA construct and 
analyzed similarly. 
 
